|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02335 MICOT PHARMA-B
Nominal 
21.980 -2.120 (-8.797%) | 2026/06 - Interim RMB(K¥) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (137,130) | (107,742) |
| Net Cash from / (used in) Investing Activities | -- | (57,582) | 54,803 |
| Net Cash from / (used in) Financing Activities | -- | 212,235 | 21,123 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 17,523 | (31,816) |
| Cash & Cash Equivalents at beginning of period | -- | 64,661 | 95,942 |
| Effect of Foreign Exchange Rate Changes | -- | (1,628) | 535 |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 80,556 | 64,661 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -230,823 |
| %Change | 372.079% |
| EPS / (LPS) | RMB -0.880 |
| NBV Per Share (¥) | RMB 2.850 |